APPLICATION NOTE

Multi-parametric assessment of compound-induced pro-arrhythmic effects in human iPSC-derived cardiomyocytes

Characterize cardiotoxic compound activity

Learn how to measure calcium oscillation in iPSC-derived cardiomyocytes for toxicity assessment.

  • Characterize CiPA cardiotoxic compounds using iPSC cardiomyocyte phenotypic assays
  • Improve calcium peak resolution with HS EMCCD camera recording up to 100 images per second.
  • Enhanced peak characterization with new ScreenWorks® Peak Pro2 software

Register to download your Application Note